Prodia Diagnostic Line Tbk vs Surya Pertiwi Tbk. — how do they compare? Prodia Diagnostic Line Tbk trades at Rp266 (market cap 470.58B, 14.52M 24h volume), while Surya Pertiwi Tbk. trades at Rp600 (market cap 1.65T, 71.3K 24h volume). The key difference: Surya Pertiwi Tbk. is far larger — about 3.5× Prodia Diagnostic Line Tbk's market cap, and Prodia Diagnostic Line Tbk is more actively traded (14.52M versus 71.3K). Which is the better fit depends on your goals.
| PRDL | SPTO | |
|---|---|---|
Market Cap | 470.58B | 1.65T |
Volume | 14.52M | 71.3K |
Lot | 145.17K | 713 |
Turnover | 3.82B | 43.1M |
Average Price | 263.17 | 604.5 |
Value | 3.82B | 43.1M |
Indicative Equilibrium Price | 272 | 610 |
Indicative Equilibrium Volume | 418 | 3.7K |
Trailing returns across standard periods
Latest headlines on both assets
PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →PT Surya Pertiwi Tbk (the Company) formerly PT Surya Nusantara was established in the Republic of Indonesia on July 5, 1978 and was published in State Gazette No. 172, Supplement No. 31 dated April 17, 1979 based on Notarial Deed No. 1 of Hendra Karyadi, S.H.
Read more on SPTO →